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Abstract
Introduction Increased serum B-type natriuretic peptide (BNP)
has been identified for diagnosis and prognosis of impaired
cardiac function in patients suffering from congestive heart
failure, ischemic heart disease, and sepsis. However, the
prognostic value of BNP in multiple injured patients developing
multiple organ dysfunction syndrome (MODS) remains
undetermined. Therefore, the aims of this study were to assess
N-terminal pro-BNP (NT-proBNP) in multiple injured patients
and to correlate the results with invasively assessed cardiac
output and clinical signs of MODS.
Methods Twenty-six multiple injured patients presenting a New
Injury Severity Score of greater than 16 points were included.
The MODS score was calculated on admission as well as 24,
48, and 72 hours after injury. Patients were subdivided into
groups: group A showed minor signs of organ dysfunction
(MODS score less than or equal to 4 points) and group B
suffered from major organ dysfunction (MODS score of greater
than 4 points). Venous blood (5 mL) was collected after
admission and 6, 12, 24, 48, and 72 hours after injury. NT-
proBNP was determined using the Elecsys proBNP® assay. The
hemodynamic monitoring of cardiac index (CI) was performed
using transpulmonary thermodilution.
Results Serum NT-proBNP levels were elevated in all 26
patients. At admission, the serum NT-proBNP values were 116
± 21 pg/mL in group A versus 209 ± 93 pg/mL in group B. NT-
proBNP was significantly lower at all subsequent time points in
group A in comparison with group B (P < 0.001). In contrast, the
CI in group A was significantly higher than in group B at all time
points (P < 0.001). Concerning MODS score and CI at 24, 48,
and 72 hours after injury, an inverse correlation was found (r = -
0.664,  P  < 0.001). Furthermore, a correlation was found
comparing MODS score and serum NT-proBNP levels (r  =
0.75, P < 0.0001).
Conclusions Serum NT-proBNP levels significantly correlate
with clinical signs of MODS 24 hours after multiple injury.
Furthermore, a distinct correlation of serum NT-proBNP and
decreased CI was found. The data of this pilot study may
indicate a potential value of NT-proBNP in the diagnosis of post-
traumatic cardiac impairment. However, further studies are
needed to elucidate this issue.
Introduction
Currently, severe trauma is still the leading cause of death in
young patients. Whereas early post-traumatic mortality is
determined by the primary traumatic impact, late mortality is
BNP: B-type natriuretic peptide; CI: cardiac index; EMOF: early-onset multiple organ failure; EVLW: extravascular lung water; ICU: intensive care unit; 
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caused by the development of sepsis and systemic inflamma-
tory response syndrome (SIRS). SIRS possibly leads to multi-
ple organ failure (MOF) and finally to multiple organ
dysfunction syndrome (MODS) [1]. In this context, cardiac
dysfunction in particular seems to be of striking relevance.
Compelling evidence has shown a significant and independ-
ent link between inflammation and cardiac dysfunction [2].
Several cytokine signaling molecules, including endothelin-1
and Toll-like receptor, have been speculated to play important
roles in the onset of cardiac dysfunction under SIRS. Involve-
ment of these pathways in cardiac dysfunction has been con-
vincingly validated in transgenic studies. Nevertheless, the
precise mechanism of action underscoring inflammation-
induced cardiac contractile dysfunction remains unclear.
Regarding the assessment of cardiac function, traditional
approaches include Swan-Ganz catheterization or echocardi-
ography [3]. These techniques are either invasive or not
always available under acute conditions in intensive care units
(ICUs). In this context, B-type natriuretic peptide (BNP) gained
significant importance in the diagnosis of congestive heart fail-
ure. BNP is a 32-amino acid protein released from cardiac ven-
tricles in response to myocyte stretch. Although plasma levels
are affected by a variety of physiological factors, BNP and
especially its cleaved N-terminal pro-BNP (NT-proBNP) have
been shown to be reliable serum markers for impaired cardiac
function. Although there is distinct evidence that NT-proBNP
might also be altered following trauma, the early dynamics of
NT-proBNP in severely injured patients developing organ fail-
ure has yet to be fully characterized [4,5]. Therefore, the aims
of this study were to assess the cardiac function in multiple
injured patients by analyzing NT-proBNP serum levels along
with an invasive hemodynamic monitoring and to correlate the
results to clinical signs of MODS.
Materials and methods
Study design and patient collective
The study was performed between January 2005 and July
2007 at our academic level 1 trauma center according to the
guidelines of Good Clinical Practice. The study was approved
by the local ethics committee (reference number 012/00).
Adult patients (> 18 years) arriving at the trauma shock unit
within 90 minutes after trauma and suffering from multiple
injury (New Injury Severity Score [NISS] of greater than 16
points) were included [6]. Written informed consent was
obtained from each patient when the patient returned to con-
sciousness or, if the patient was still unconscious, from the
next of kin or a legal representative. Patients dying within 24
hours after the incident or with initial myocardial injury were
excluded. Patients with traumatic brain injury, identified by
signs of intracranial hemorrhage on the initial routine follow-up
computed tomography scan, were excluded as well [7]. Fur-
ther exclusion criteria to eliminate bias by pre-existent altera-
tions of NT-proBNP were previous cardiac, renal, hepatic, or
endocrine diseases prior to admission (for exclusion criteria,
see Figure 1). After the initial resuscitation and primary surgi-
cal interventions necessary in accordance with the present
standards of care, patients were admitted to the ICU. The
baseline characteristics such as age, gender, mechanism of
injury, and past medical history were retrieved subsequently.
For the entire observation period, the 24-hour volume of fluid
resuscitation as well as the 24-hour urinary output volume
were recorded. All treatment data and measured parameters
assessed in the trauma shock unit, operating room, and ICU
were prospectively collected and recorded in a structured
form database for each patient.
Marshall multiple organ dysfunction score
The MODS score is an established and validated scoring sys-
tem that includes the function of six different organ systems
[8]. It combines measures of physiologic dysfunction in six
components: cardiovascular (heart rate × right atrial pressure/
mean arterial pressure), respiratory (arterial partial pressure of
oxygen/fraction of inspired oxygen [PaO2/FiO2]), renal (serum
creatinine), central nervous system (Glasgow Coma Scale
score), hepatic (serum bilirubin), and hematologic (platelet
count). Each component score provides a quantitative meas-
ure of physiologic function over 24 hours such that 0 repre-
sents normal function and 1, 2, 3, and 4 represent increasing
physiologic derangement. Values of each component are
summed on a daily basis to produce a daily score; the highest
total MODS score is 24. A cumulated MODS score of greater
than 4 points is associated with a 2.4-fold higher hospital mor-
tality and a 2-fold longer ICU stay. Mortality increases from 7%
to 17% and the duration of intensive care increases from 3 to
6 days [9]. MOF is defined as the occurrence of severe organ
failure in two or more organ systems during the treatment
period, either on the same or on different days. The MODS
score was calculated on admission as well as 24, 48, and 72
hours after injury. According to the MODS score, patients
were divided in two subcollectives: group A had minor organ
dysfunction (cumulated MODS score of less than or equal to
4 points on 2 consecutive days) and group B had major organ
dysfunction (cumulated MODS score of greater than 4 points
on 2 consecutive days). The outcome of the patients was eval-
uated 90 days after trauma.
Analysis of NT-proBNP in serum
According to a serial protocol, 5 mL of venous blood was col-
lected in a sterile tube containing EDTA (ethylenediamine-
tetraacetic acid). Sampling points were as follows:
immediately after admission to the trauma shock unit (within
90 ± 45 minutes after injury) and 6, 12, 24, 48, and 72 hours
after trauma. The concentration of NT-proBNP was deter-
mined using a commercially available electrochemilumines-
cence immunoassay (Elecsys proBNP®  assay; Roche
Diagnostics, Indianapolis, IN, USA), as described previously
[7]. Synthetic human NT-proBNP was used for
standardization.Available online http://ccforum.com/content/12/5/R118
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Hemodynamic evaluation
The hemodynamic monitoring, including permanent invasive
measurement of the cardiac output (cardiac index, CI), was
performed by transpulmonary thermodilution (TPTD). TPTD
measurements were performed using the Pulsiocath 5-French
thermistortipped catheter (Pulsion Medical Inc., Irving, TX,
USA). The assessment was started on admission to the ICU
and was continued for the entire observation period. The CI
and extravascular lung water (EVLW) were recorded 24, 48,
and 72 hours after trauma. The assessment was performed
three times in a row and the values were averaged [10].
Statistical analysis
Statistical significance between groups was determined by
analysis of variance on ranks, followed by Tukey method as a
post hoc test. A P value of less than 0.05 was considered to
be statistically significant. For calculating the correlations
between NT-proBNP values and MODS score as well as
between NT-proBNP values and CI, bivariate analyses with
Spearman correlation were calculated. A P value of less than
0.001 was considered to be statistically significant. Data are
given as mean ± standard error of the mean. Analyses were
performed using the Sigma Stat 3.0 software package (SPSS
Inc., Chicago, IL, USA).
Figure 1
Flowchart depicting the criteria for excluding patients from the present study Flowchart depicting the criteria for excluding patients from the present study. The number of patients excluded for each criterion is given. NISS, New 
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Results
Demographic and clinical data
During the study period, 40 out of 185 patients fulfilled the
inclusion criteria. Fourteen patients died within 24 hours after
trauma and thus were excluded. A remainder of 26 patients
(20 men and 6 women) survived the observation period and
were enrolled in the study (for detailed information, see Figure
1). Patient ages ranged from 23 to 75 years, with a mean of
43 ± 13 years (mean ± standard deviation [SD]), and the
NISS ranged from 19 to 75 points, with a mean of 35 ± 10
(mean ± SD). Twenty-two patients made uneventful recover-
ies, and four with a MODS score of greater than 4 died due to
MOF on days 11, 18, 34, and 46 after injury. The major reason
for multiple injury was a blunt mechanism like a traffic accident
or a fall from a height. The volume of fluid resuscitation
required in the first 72 hours ranged from 12 to 54 L. Within-
subject analysis revealed no correlation of NT-proBNP and
resuscitation volume over time. Clinical baseline characteris-
tics, such as injury patterns, age, gender, NISS, and Glasgow
Coma Scale score, within the first 72 hours are given in Table
1.
Marshall multiple organ dysfunction score
Sixteen patients (group A) had a cumulated MODS score of
less than or equal to 4 points during the entire observation
period. All patients within this group survived. Ten patients
(group B) had a cumulated MODS score of greater than 4
points on at least 2 consecutive days; out of this group, 4
patients died. Twenty-four hours after injury, the MODS scores
were 2.0 ± 0.3 points in group A versus 5.1 ± 0.4 points in
group B. Forty-eight hours after trauma, the MODS scores
were 1.8 ± 0.3 points in group A versus 5.9 ± 0.8 points in
group B and 72 hours after injury were 1.9 ± 0.3 points in
group A versus 7.0 ± 0.8 points in group B. Therefore,
patients in group A had a significantly lower MODS score at
all observation points (P < 0.001). None of the patients had a
MODS score of greater than 12 points. There was no statisti-
cally significant difference between the patients with different
MODS scores regarding patient age, gender distribution, or
severity of injury according to NISS.
Analysis of NT-proBNP in serum
Serum NT-proBNP levels were increased in all 26 patients
(156 samples analyzed) in comparison with norm values (P <
0.001). At admission, the mean serum NT-proBNP levels were
116 ± 21 pg/mL in group A versus 209 ± 93 pg/mL in group
B. Six hours after injury, the serum NT-proBNP levels were
124 ± 20 pg/mL in group A versus 224 ± 78 pg/mL in group
B. Twelve hours following admission, the serum NT-proBNP
levels were 140 ± 23 pg/mL in group A versus 378 ± 104 pg/
mL in group B. Twenty-four hours after injury, the serum NT-
proBNP levels were 201 ± 39 pg/mL in group A versus 729
± 164 pg/mL in group B. Forty-eight hours after injury, the
serum NT-proBNP levels were 253 ± 39 pg/mL in group A
versus 1,616 ± 337 pg/mL in group B. Seventy-two hours
after injury, the serum NT-proBNP levels were 196 ± 44 pg/
mL in group A versus 1,899 ± 405 pg/mL in group B. There-
fore, patients in group A had lower NT-proBNP serum levels at
all points of observation. This difference was statistically signif-
icant at 24, 48, and 72 hours after injury (P < 0.001) (Figure
2).
Hemodynamic evaluation
The CI was reduced in all patients at all time points (24, 48,
and 72 hours). Twenty-four hours after injury, CIs in group A
were 4.0 ± 1.4 L/minute/m2 versus 3.2 ± 1.9 L/minute/m2 in
group B. At 48 hours, the CIs were 3.8 ± 1.5 L/minute/m2 in
group A versus 3.0 ± 0.9 L/minute/m2 in group B. Seventy-two
hours after injury, the CIs were 4.1 ± 1.8 L/minute/m2 in group
A versus 2.8 ± 1.9 L/minute/m2 in group B. The CI of group A
was significantly higher in comparison with group B at all time
points (P < 0.001) (Figure 3). There were no statistical differ-
ences concerning EVLW observed (data not shown).
Correlation of clinical data and NT-proBNP
A strong inverse correlation was found in comparing the cumu-
lated MODS score and CI at 24, 48, and 72 hours after injury
(r = -0.664, P < 0.001). Furthermore, there was a strong cor-
relation in comparing the MODS score and serum NT-proBNP
levels (r = 0.75, P < 0.0001).
Discussion
In this study, we demonstrated a sequential analysis of serum
NT-proBNP and simultaneously assessed cardiac output
using invasive measurement. A distinct correlation of
increased NT-proBNP levels and decreased cardiac output in
multiple injured patients was observed 24 hours after trauma.
These changes were attributed to the development of clinical
signs of post-traumatic organ dysfunction.
Diagnostic value of NT-proBNP
BNP was originally identified in extracts of porcine brain as
well as in the human hypothalamus and cardiac tissue [11].
The protein is distributed as a proactive form of proBNP, com-
prising 108 amino acids, and is then cleaved into the biologi-
cally active BNP (32 amino acids) and an inactive 76-residue
N-terminal fragment (NT-proBNP). Although only BNP turns
out to be biologically active in renal target cells, the cleaved
NT-proBNP can be measured with higher sensitivity and accu-
racy due to its longer amino acid sequence [12]. Since the NT-
proBNP and BNP levels directly correspond to each other, the
NT-proBNP was analyzed in this study. BNP was initially
described as a biomarker for the identification of patients suf-
fering from congestive heart failure. Elevated serum levels
were also found in patients with left ventricular dysfunction
and ventricular pressure overload status such as pulmonary
embolism, cor pulmonale, and primary pulmonary hypertension
[13].Available online http://ccforum.com/content/12/5/R118
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Table 1
Clinical baseline characteristics
Patient Injury pattern NISS GCS score 
at 0 hours
Age, years Gender BNP at 
72 hours
MODS score 
at 72 hours
CI at 72 
hours
Outcome at 
90 days
Group A (n = 16)
1 Lung contus. bs, spleen capsular hemat., minor nephral 
contus.
24 15 23 Male 225 0 4.1 Survived
2 Le Fort III°, lung contus., hemo-pneumoth. ls, bs open 
femur # II°
34 15 29 Male 64 0 5.7 Survived
3 Vault #, lung contus. bs, serial rib # bs, hemo-
pneumoth. rs, spleen hemat.
36 13 44 Female 104 1 4.2 Survived
4 Commotio cerebri, lung contus. bs, scapula #, open 
fibula # II°
24 13 45 Male 105 1 4.8 Survived
5 C5 facet # with incomp. cord syndrome, lung contus. ls, 
liver rupture, nephral contus. ls
34 14 34 Male 24 1 4.7 Survived
6 Lung contus. ls, serial rib #, pneumoth. rs, amputation 
below knee, bite injury lower lip
29 14 58 Male 89 1 4.2 Survived
7 Skull base #, vault #, lung contus. bs, pneumoth. ls, 
serial rib # ls, radius #
29 12 36 Male 22 2 4.8 Survived
8 Serial rib # ls, pneumoth. ls, liver rupture, spleen 
rupture, humerus shaft #
41 13 43 Male 543 2 2.9 Survived
9 Commotio cerebri, scalp laceration, lung contus. ls, 
pneumoth. ls, serial rib # ls, acetabulum #, os 
ischiadicum #, os ilium #
45 11 32 Female 91 2 3.8 Survived
10 Lung contus. bs, serial rib # ls, spleen rupture, 
mesentery rupture with major blood loss, femur #
27 13 62 Male 526 2 2.9 Survived
11 Mild lung contus., amputation below knee rs, femur # rs 19 15 45 Male 158 2 4.4 Survived
12 C7 # displaced with cord contus., serial rib # ls, lung 
contus. bs, pneumoth. ls, spleen rupture, humerus # ls
34 14 25 Female 96 2 3.4 Survived
13 Lung contus. rs, L3 #, os ileum, os ischiadium, os pubis 
#, femur #, trimalleolar #
27 12 57 Female 52 3 4.1 Survived
14 Scalp contus., C5 # with complete cord syndrome, lung 
contus. bs, shoulder dislocation
50 13 39 Female 399 3 4.2 Survived
15 Commotio cerebri, scalp laceration, lung contus. bs, 
hemo-pneumoth., serial rib # ls, os ileum #, os 
ischiadium #, os pubis #
24 11 75 Male 364 4 3.8 Survived
16 Lung contus. bs, serial rib #, T1-3 process spinal #, 
femur shaft #, open tibia # III°
34 11 40 Female 276 4 4.1 Survived
Group B (n = 10)
17 Le Fort II°, serial rib # rs, pneumoth. rs, lung contus. bs, 
liver rupture, multiple upper and lower extremity #
48 13 35 Male 119 5 4.1 † (18 days)
18 Lung contus. bs, L1 compression #, tibia #, bimalleolar 
# bs, fibula shaft #, calcaneus #
34 15 48 Male 885 5 3.3 Survived
19 Major muscle damage, humerus #, open tibia # II°, open 
fibula # II°
22 11 33 Male 666 5 3.2 Survived
20 Vault #, Le Fort II°, lung contus. bs, hemato-pneumoth., 
serial rib # ls, massive shoulder destruction
34 11 46 Male 552 5 2.8 Survived
21 Commotio cerebri, scalp laceration, lung contus. rs, 
lung laceration rs, hemato-pneumoth. bs, A. iliaca int. 
rupture rs, scapula #
41 10 34 Male 2,809 6 2.6 Survived
22 Lung contus. bs, L2 compression #, L3 L4 #, 
retroperiton hemat., acetabulum #, sacrum #
34 15 33 Male 2,621 7 2.6 Survived
23 Lung contus. bs, serial rib # bs, hemato-pneumoth., 
diaphragm rupture, mesentery laceration, femur #
57 13 59 Male 1,654 7 2.6 † (34 days)
24 Serial rib # bs, hemo. bs, sternum #, mesentery rupture, 
femur #
41 13 57 Male 2,813 7 3.0 SurvivedCritical Care    Vol 12 No 5    Kirchhoff et al.
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Post-traumatic alterations of NT-proBNP
In the present study, a significant increase of more than 100
pg/mL in NT-proBNP levels was observed on admission in all
patients. Few studies have attempted to define the normal
value of NT-proBNP or to find the cutoff value that allows the
best balance between sensitivity and specificity. There is evi-
dence that a single cutoff value cannot be chosen for all
patients. Age, gender, body mass index, and race seem to
affect the normal range of BNP. Several studies have shown
that BNP values of less than 100 pg/mL are very specific for
normal heart function [14]. Regarding the issue of BNP alter-
ation in trauma patients, Kia and colleagues [15] reported
BNP levels below normal as an indicator for intravascular vol-
ume loss and therefore as an initial marker of bleeding. Stewart
and colleagues [4] recently analyzed BNP and transthoracic
echocardiogram in trauma patients and found no correlation of
BNP and cardiac dysfunction. However, there are several
technical drawbacks in their study, leading to results contrary
to those presented by us. In our study, invasive hemodynamic
monitoring was performed using TPTD. According to the liter-
ature, thermodilution seems to be superior to transesophageal
and especially transthoracic echocardiogram and currently
represents the clinical standard for the determination of car-
diac output [3]. We enrolled only severely injured patients with
an NISS of greater than 16 points since it is well known that
development of MODS significantly depends on the initial
severity of injury [16]. In contrast, Stewart and colleagues [4]
did not address the issue of injury severity in their work. In the
present study, patients with intracranial hemorrhage were
excluded in order to eliminate alteration of BNP caused by
total body irradiation (TBI). This also is in contrast to Stewart
and colleagues, who enrolled patients with TBI and observed
an elevation of BNP independent of cardiac function. How-
ever, these findings are not new since it has been shown that
systemic inflammatory reaction following TBI also leads to ele-
vated systemic NT-proBNP levels [7]. In a second study focus-
25 Orbit #, thoracic cavity injury with pneumoth., aortic 
dissection, liver rupture < 3 segments, femur #
48 11 49 Male 3,089 11 2.1 † (46 days)
26 Serial rib #, hemo-pneumoth., lung contus. bs, 
amputation below knee rs, femur #
33 14 32 Male 3,785 12 2.1 † (11 days)
Group A consisted of patients with a multiple organ dysfunction syndrome (MODS) score of less than or equal to 4 points, and group B consisted of patients with a 
MODS score of greater than 4 points. Time values refer to time after trauma. †, deceased; #, fracture; A. iliaca int., internal iliac artery; BNP, N-terminal pro-B-type 
natriuretic peptide; bs, both sides; CI, cardiac index; contus., contusion; GCS, Glasgow Coma Scale; hemat., hematoma; hemato-pneumoth., hematothorax-
pneumothorax; hemo-pneumoth., hemothorax-pneumothorax; hemo, hemothorax; incomp, incomplete; ls, left side; NISS, New Injury Severity Score; pneumoth., 
pneuomothorax; rs, right side.
Table 1 (Continued)
Clinical baseline characteristics
Figure 2
Serum concentrations of N-terminal pro-B-type natriuretic peptide (NT- proBNP) in 26 multiple injured patients Serum concentrations of N-terminal pro-B-type natriuretic peptide (NT-
proBNP) in 26 multiple injured patients. Group A (circles) consisted of 
patients with a multiple organ dysfunction syndrome (MODS) score of 
less than or equal to 4 points (n = 16 patients), and group B (triangles) 
consisted of patients with a MODS score of greater than 4 points (n = 
10 patients). Data were calculated on admission and at 6, 12, 24, 48, 
and 72 hours after trauma and are presented as mean ± standard error 
of the mean. *P < 0.001 group A versus group B.
Figure 3
Cardiac index assessed by invasive transpulmonary thermodilution in  26 multiple injured patients Cardiac index assessed by invasive transpulmonary thermodilution in 
26 multiple injured patients. Group A (circles) consisted of patients 
with a multiple organ dysfunction syndrome (MODS) score of less than 
or equal to 4 points (n = 16 patients), and group B (triangles) consisted 
of patients with a MODS score of greater than 4 points (n = 10 
patients). Data were calculated on admission and at 6, 12, 24, 48, and 
72 hours after trauma and are presented as mean ± standard error of 
the mean. *P < 0.001 group A versus group B.Available online http://ccforum.com/content/12/5/R118
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ing on BNP dynamics following trauma, Friese and colleagues
[5] suggested that serum BNP might act as a biomarker for the
preload status during resuscitation after injury. This is in con-
trast to our data since we did not observe significant differ-
ences regarding volume resuscitation. We also did not
observe differences regarding EVLW. Friese and colleagues
[5] also stated that detection of pulmonary edema on chest
radiograph might not be the optimal tool to identify the pres-
ence of fluid overload. In this context, several authors demon-
strated that measurement of EVLW correlates significantly to
the degree of pulmonary edema and has substantial prognos-
tic value in critically ill patients.
Systemic inflammatory response and NT-proBNP
The main observation of this study is that patients with
increased clinical signs of organ dysfunction following multiple
injury had significantly increased NT-proBNP levels of greater
than 200 pg/mL on admission, increasing to greater than
1,600 pg/mL 72 hours after trauma, in comparison with
patients with fewer signs of organ dysfunction. Moreover, out
of the group with a MODS score of greater than 4 points, four
patients died. At 72 hours after trauma, these patients
revealed NT-proBNP levels of up to 3,700 pg/mL. However,
comparing both groups, the first significant difference regard-
ing NT-proBNP levels was found as early as 24 hours after
trauma.
Moore and colleagues [17] suggest different types or phases
of MOF: an early-onset MOF (EMOF) occurring on days 0 to
3 after trauma, and a late-onset MOF (LMOF) starting 3 days
after trauma. In this context, Maier and colleagues [1] differed
between EMOF and LMOF with reference to the affected
organ system by assessing cytokines at admission and at 24,
48, and 72 hours [1]. Although the aim of trauma research is
to detect MOF as early as possible, this time protocol seems
to be representative for current studies. However, we suggest
a close meshed protocol as this might allow for an earlier
detection of pathologic changes.
Multiple organ dysfunction in the present study was quantified
according to our clinical protocol using the MODS score, first
published by Marshall and colleagues [8]. The reliability of the
MODS score as an outcome predictor has been demon-
strated, and the correlation between a high degree of organ
failure as assessed by the sequential organ failure assessment
(SOFA) score and mortality is well established [8]. Peres Bota
and colleagues [9] demonstrated that the MODS score and
the SOFA score correlate well with the outcome in terms of
mortality prediction and with the APACHE II (Acute Physiology
and Chronic Health Evaluation) score. However, Ertel and
colleagues [19] reported that the MODS score had a better
correlation to development of SIRS and seemed to be more
predictive for post-traumatic complications and outcome of
injured patients.
The correlation of clinical signs of organ dysfunction and
increased NT-proBNP levels is absolutely in line with other
authors focusing on the predictive value of NT-proBNP in crit-
ical illness. Kandil and colleagues [20] recently confirmed the
relationship between BNP level elevation and severity of sep-
sis independent of congestive heart failure. Also, in some
patients, inflammatory cascades following cardiovascular sur-
gery result in severe postoperative complications, including
renal, hepatic, and neurological dysfunction, or respiratory and
cardiovascular failure. In patients who underwent cardiac sur-
gery, Kerbaul and colleagues [21] recently found a significant
correlation of postoperative severe SIRS and elevated serum
NT-proBNP concentrations. Moreover, they observed that NT-
proBNP concentrations are elevated in cardiac disease in pro-
portion to the severity of left ventricular dysfunction. The
authors stated that the preoperative plasma concentrations of
NT-proBNP could be a valuable predictor of severe SIRS
associated with cardiovascular dysfunction [21].
Regarding the origin of BNP, Yasue and colleagues [22]
determined that BNP is secreted mainly from the left ventricle
in healthy adults as well as in patients with left ventricular dys-
function. They also showed that increased wall tension of the
left ventricle results in an increase in the rate of BNP secretion.
Because of this relationship, Yasue and colleagues proposed
BNP level as a marker of the degree of left ventricular dysfunc-
tion. Although the underlying cause of SIRS-induced myocar-
dial dysfunction remains unclear, one theory speculates on the
presence of a circulating myocardial depressant substance;
other investigators have shown a relationship between myo-
cardial depression and different cytokines, including inter-
leukin-1-beta and tumor necrosis factor-alpha [2]. These
proinflammatory cytokines are known to be significantly ele-
vated in patients with sepsis as well as in multiple injured
patients [1]. The myocardial depressant effect of these
cytokines has been linked to mechanisms involving nitric oxide
generation [2].
Conclusion
Twenty-four hours after trauma, serum NT-proBNP levels sig-
nificantly correlate with clinical signs of MODS in multiple
injured patients. Late mortality in these patients is caused
mainly by multiple organ dysfunction and failure. Furthermore,
serum NT-proBNP levels significantly correlate with a
decreased CI as a parameter for cardiovascular function. The
data of this pilot study may indicate a potential value of NT-
proBNP in the diagnosis of post-traumatic cardiac impairment.
However, further studies are necessary to elucidate this issue.
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Key messages
￿  N-terminal pro-B-type natriuretic peptide (NT-proBNP) 
levels are significantly increased 24 hours after severe 
multiple injury in patients with major signs of organ dys-
function in comparison with patients with minor organ 
dysfunction.
￿  Although this study presents only pilot data and does 
not allow for a direct clinical implication, NT-proBNP 
might serve as a tool for risk stratification in multiple 
injured patients.
￿  Further studies are necessary to analyze the value of 
NT-proBNP in the diagnosis of post-traumatic cardiac 
impairment.